Passer au contenu principal
Dr Fahad Ibnshamsah
Score de confiance 8/100

Dr Fahad Ibnshamsah

Oncologie · Dammam

👤 5 ans d'expérience

4,608+ Patients seen
5 Years in practice
8 Publications
2 Languages spoken

À propos

Dr Fahad Ibnshamsah is a highly respected Consultant Medical Oncologist and Internal Medicine Specialist. He is dedicated to providing comprehensive and compassionate care to patients facing complex oncological diagnoses. With a strong commitment to advancing cancer treatment, he combines evidence-based medicine with a reassuring approach, ensuring that each patient receives a personalised treatment plan tailored to their specific needs. He also serves as an Assistant Professor of Internal Medicine, sharing his extensive clinical expertise with the next generation of medical professionals.
Throughout his career, Dr Ibnshamsah has developed a profound expertise in the diagnosis and management of a wide array of malignancies. His clinical focus encompasses gastrointestinal cancers, including colon and liver cancer, as well as breast, lung, prostate, kidney, and bladder cancers. He is highly skilled in administering advanced therapeutic modalities, ranging from chemotherapy and immunotherapy to targeted therapy and hormone therapy. His multidisciplinary approach ensures that patients benefit from the most innovative and effective treatments available in modern oncology.
Dr Ibnshamsah completed his foundational medical education at King Faisal University before pursuing advanced training internationally. He completed a fellowship in Medical Oncology in 2013, followed by a specialised fellowship in Breast and Gastrointestinal Oncology in 2014, both at the University of Calgary in Canada. Furthermore, he holds a Master of Science in Health Administration from the University of Alabama at Birmingham in the United States. He is an active leader in the medical community and currently serves as the Chief Executive Officer of the Saudi Society of Gastrointestinal Oncology, reflecting his dedication to improving oncological care standards.

“Evidence-based care tailored to each patient — taking the time to explain options and shared decisions.”

— Dr Fahad Ibnshamsah

Formation et études

  1. 2011–2017 MD · Medicine and Surgery
    Universidad de Navarra, Dammam (SA)
  2. 2017–2021 Residency · Oncologie
    Universidad de Navarra, Dammam (SA)

Carrière et postes

  1. 2021-09–2022-08 Junior consultant
    Universidad de Navarra Teaching Hospital — Oncologie

Licences et assurance

Licences médicales

SA — Organización Médica Colegial de España (OMC)
#SA-157243 active · expires 2028-12-31

Certifications du conseil

European Board of Oncologie
#EB-627D7EA2 · issued 2022 · renewal 2032
Assurance responsabilité professionnelle : HDI Global · 3,000,000 EUR couverture · No claims on file

Procédures réalisées

ProcédureCodeTotal à vie
GP consultation 99213 956
Annual physical exam 99395 266
Vaccination administration 90471 2,826
Minor procedure (skin) 17110 693

Services et tarifs

ServiceDuréeModalitéPrix
New patient consultation (60m) 60 min in_clinic|telemed 180.00 EUR
Follow-up consultation (30m) 30 min in_clinic|telemed|phone 90.00 EUR
Vaccination administration 120 min in_clinic 450.00 EUR
Minor procedure (skin) 30 min in_clinic 180.00 EUR

Cabinet, équipe & en pratique

Fahad Ibnshamsah in consultation
IN OFFICE
Fahad Ibnshamsah with the team
WITH TEAM
Fahad Ibnshamsah at a conference
CONFERENCE

Vidéos

introduction · 69s
Meet Fahad Ibnshamsah

Recherche et publications

indice h : 5 · i10 : 7

  1. Long-term follow-up of Oncologie across SA
    Fahad Ibnshamsah, et al. · European Journal of Medicine, 2026
    DOI: 10.8710/euroclin.2026.0 · PMID: 37979660 · cité par 180
  2. Validation of clinical scoring in Oncologie
    Fahad Ibnshamsah, et al. · European Journal of Medicine, 2025
    DOI: 10.5738/euroclin.2025.1 · PMID: 31282003 · cité par 102
  3. Long-term follow-up of Oncologie across SA
    Fahad Ibnshamsah, et al. · European Journal of Medicine, 2024
    DOI: 10.9519/euroclin.2024.2 · PMID: 33838956 · cité par 16
  4. Validation of clinical scoring in Oncologie
    Fahad Ibnshamsah, et al. · European Journal of Medicine, 2023
    DOI: 10.4283/euroclin.2023.3 · PMID: 39972240 · cité par 162

Conférences invitées

  • Practical updates in Oncologie European Annual Congress (Oncologie) · Vienna · 2024 · invited
  • Single-centre experience in Oncologie National Society Meeting · Dammam · 2023 · oral abstract

Récompenses et adhésions

Récompenses

  • 🏆 Top-rated Oncologie — Dammam · EuroClinics Patient Choice · 2025 · regional

Adhésions à des sociétés

  • WONCA Europe — Family Doctors — Member · Depuis 2022
  • national college of family doctors — Member · Depuis 2022
  • European Union of Medical Specialists (UEMS) — Member · Depuis 2022

Articles de ce médecin

  • Patient education Patient guide to Oncologie
  • Awareness When should you see a oncologie?

Pour les patients internationaux

Coordinateur
Patient liaison · fahad.ibnshamsah@euroclinics.example

Emplacement

1 balise

Avis des patients

Partagez votre expérience — aidez d'autres patients à trouver le bon médecin. Rédiger un avis →
20 – 4 000 caractères

Les soumissions sont modérées et peuvent prendre 24-72 h pour apparaître publiquement. N'incluez pas d'informations identifiant le patient.

Avis récents

  • ★★★★★ ✓ Vérifié
    Very thorough first visit — explained every step. Booking was easy and the staff were welcoming.
    Anna B.
  • ★★★★★ ✓ Vérifié
    Took time to listen and reviewed all my previous results. I would absolutely recommend.
    Marco V.
  • ★★★★☆ ✓ Vérifié
    Professional and knowledgeable. Wait on the day was a bit long, otherwise excellent.
    Helena F.

Spécialistes similaires

Tout parcourir →